End of Day Message

LONDON, 21 Mar. 2024 (GLOBE NEWSWIRE) -- This is the End of Day Message for GlobeNewswire.

GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information provider.

Disclaimer

The content and accuracy of all information distributed through Notified is wholly the responsibility of the originator. Notified accepts no liability for any losses arising from reliance by any person upon the content of any announcement.

If you have any questions about this message, please Contact Us.

You May Also Be Interested In

• Amplio Pharma Reports Positive Early Clinical Results for NovoBioJect, Designed to Make the World's Most-Used Rheumatoid Arthritis Drug Work for More Patients
• BioMedNewsBreaks — HealthLynked Corp. (OTCQB: HLYK) Selects DRCARE247 as Telemedicine Partner 
• H2O America Completes Texas Subsidiary’s Acquisition of Quadvest